Caricamento...
基因芯片筛选CD133(+)/CD133(-)肺腺癌细胞中新的耐药基因
BACKGROUND AND OBJECTIVE: Cancer stem cells (CSCs) are responsible for multi-drug resistance in tumors. CD133 is a known biomarker of CSCs. The aim of this study is to screen for drug-resistant differentially expressed genes in CD133(+) and CD133(-) lung cancer cells and to identify novel lung tumor...
Salvato in:
| Pubblicato in: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
中国肺癌杂志编辑部
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000102/ https://ncbi.nlm.nih.gov/pubmed/24949682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2014.06.01 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|